Skip to main content
. 2013 Jun 18;8(6):e65889. doi: 10.1371/journal.pone.0065889

Figure 6. Piperine treatment abrogates migration of prostate cancer cells in vitro.

Figure 6

Boyden chamber assay shows that control LNCaP and PC-3 prostate cancer cells have a greater number of migrated cells while LNCaP and PC-3 samples treated with 60 µM and 75 µM piperine show fewer migrated cells in Transwell® chambers. Arrow indicates migrated cells. The inhibition of cell migration suggests that piperine may have anti-migratory properties in prostate cancer. Data shown here is representative of one of three similar results obtained.